Literature DB >> 12838009

Delayed-onset facial paralysis after vestibular neurectomy.

Jeffrey T Vrabec1, Newton J Coker, Herman A Jenkins.   

Abstract

OBJECTIVES/HYPOTHESIS: Delayed-onset facial paralysis (beginning more than 3 d after the procedure) has been described as a complication of many different types of otological procedures. The incidence of this problem in vestibular neurectomy and the relationship to surgical approach are detailed in the study. STUDY
DESIGN: Retrospective case review.
METHODS: In the setting of a tertiary referral center, vestibular neurectomy was performed in 70 individuals with disabling vertigo unresponsive to medical therapy who elected vestibular neurectomy. The main outcome measure was incidence of delayed onset facial paralysis.
RESULTS: Delayed-onset facial paralysis was significantly more common after the middle fossa (18%) and translabyrinthine (11%) approaches compared with the retrosigmoid approach (0%).
CONCLUSIONS: Surgical approach influences the incidence of delayed-onset facial paralysis. Measures to prevent this complication such as prophylactic antiviral medication or labyrinthine segment decompression may be considered in middle fossa and translabyrinthine operations.

Entities:  

Mesh:

Year:  2003        PMID: 12838009     DOI: 10.1097/00005537-200307000-00006

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Revision surgery after triple semicircular canal plugging and morphologic changes of vestibular organ.

Authors:  Daogong Zhang; Yafeng Lv; Yuechen Han; Gaoying Sun; Yawei Li; Xiaofei Li; Lixin Sun; Ruozhen Gong; Zhaomin Fan; Haibo Wang
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

2.  Efficacy of Resection of Lateral Wall of Endolymphatic Sac for Treatment of Meniere's Disease.

Authors:  Daogong Zhang; Yafeng Lv; Xiaofei Li; Yongdong Song; Ligang Kong; Zhaomin Fan; Haibo Wang
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.